Statistics in medical journals: Developments in the 1980s

Statistics in Medicine

Volumn 10, Issue 12, 1991, Pages 1897-1913

  Altman, Douglas G ^a  

^a Stats Consultancy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITERATURE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICINE; POLICY; REVIEW; STATISTICAL ANALYSIS; STATISTICS;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMAN; MODELS, STATISTICAL; PERIODICALS; PUBLISHING; RESEARCH DESIGN; STATISTICS;

EID: 0026320717     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4780101206     Document Type: Article

References (126)

1. Application of statistical methods in physiology
2. What is wrong with the medical curriculum?
3. Statistical evaluation of medical journal manuscripts
4. Biometry and medical statistics
5. Misuse of statistical methods in Arthritis and Rheumatism. 1982 versus 1967–68
6. Use of statistical analysis in the New England Journal of Medicine
7. Impact of multiple comparisons in randomized clinical trials
8. Methodology and overt and hidden bias in reports of 196 double‐blind trials of non‐steroidal antiinflammatory drugs in rheumatoid arthritis
9. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
10. Survival analysis 1982–1991: the second decade of the proportional hazards regression model
11. Regression models and life tables
12. Quantitative methods in the review of epidemiologic literature
13. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
14. Whither meta‐analysis
15. Meta‐analysis in clinical research
16. Accumulating evidence: using meta‐analysis to carry out research reviews in pediatrics
17. Overviews of randomized clinical trials
18. Confidence limits in evaluating controlled therapeutic trials
19. A show of confidence
20. Confidence intervals rather than P values: estimation rather than hypothesis testing
21. Confidence intervals for reporting results of clinical trials
22. Confidence intervals vs significance tests: quantitative interpretation
23. Confidence intervals
24. Randomisation and baseline comparisons in clinical trials
25. The end of the p value?
26. Memories of the British streptomycin trial in tuberculosis. The first randomized clinical trial
27. Evidence and scientific research
28. Empirical Bayes estimates of age‐standardized relative risks for use in disease mapping
29. Statistical tools for subset analysis in clinical trials
30. Estimation issues in clinical trials and overviews
31. Empirical Bayes estimates of subgroup effects in clinical trials
32. Statistical problems in the reporting of clinical trials. A survey of three medical journals
33. Why do we need some large, simple randomized trials?
34. A randomized trial of induction chemotherapy plus high‐dose radiation versus radiation alone in stage III non‐small‐cell lung cancer
35. Chemotherapy and radiation therapy as compared with radiation therapy in stage III non‐small‐cell cancer
36. Play‐the‐winner rule and the controlled clinical trial
37. Adaptive treatment assignment methods and clinical trials
38. A new design for randomized clinical trials
39. Extracorporeal circulation in neonatal circulatory failure a prospective randomized study
40. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study
41. Investigating therapies of potentially great benefit: ECMO
42. Neonatal extracorporeal membrane oxygenation: how not to assess novel technologies
43. Randomized consent designs for clinical trials: an update
44. Randomization designs in comparative clinical trials
45. Strategy and alternate randomized designs in cancer clinical trials
46. Design considerations for AIDS trials
47. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
48. Comment: ethics and ECMO
49. Using observational data from registries to compare treatments: the fallacy of omnimetrics
50. Potentials and limitations of database research
51. Towards estimation and confidence intervals
52. Estimating with confidence
53. Statistics in medical journals
54. Methodologic guidelines for reporting results of clinical trials
55. Aid to the evaluation of therapeutic studies
56. Reporting controlled trials
57. Guidelines for the documentation of epidemiological studies
58. Guidelines for reading case‐control studies
59. Reporting observational studies
60. The assessment of diagnostic tests. A survey of current medical research
61. Reporting the assessment of screening and diagnostic tests
62. Meta‐analyses of randomized controlled trials
63. Statistical guidelines for contributors to medical journals
64. Uniform requirements for papers submitted to biomedical journals
65. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations
66. Use of check lists in assessing the statistical content of medical studies
67. Presentation of variability
68. Uniform requirements for manuscripts: the new, third edition
69. Analysis of survival by tumor response
70. Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials
71. Guidelines for reporting clinical trials
72. Tamoxifen therapy in advanced/recurrent endometrial carcinoma
73. Assessing the effect of toxicity on prognosis: methods of analysis and interpretation
74. Sikkerhedsintervaller‐radaktionens indstilling
75. Words on numbers: statistics in medical journals
76. More informative abstracts revisited
77. Editorial
78. Publication decisions and their possible effects on inferences drawn from tests of significance ‐ or vice versa
79. Publication bias: a problem in interpreting medical data (with discussion)
80. Publication bias in clinical research
81. Biased touching of the editorial tiller
82. Clinical trials ‐ meta‐analysis, confidence limits and ‘intention to treat’ analysis
83. Towards a reduction in publication bias
84. Editorial review of protocols for clinical trials
85. An exploratory study of statistical assessment of papers published in the British Medical Journal
86. Statistics in medical journals: a survey of current policies and proposals for editors
87. Successful intermittent chemoprophylaxis for pneumocystis carinii pneumonitis
88. Rates of thromboembolism with three different mechanical heart valve prostheses: randomised study
89. Endoscopic sphincterotomy in 1000 consecutive patients
90. 40‐year follow‐up of overweight children
91. Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay
92. Exposure of midwives to nitrous oxide in four hospitals
93. Randomized controlled trial of a monoclonal antibody against the interleukin‐2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts
94. Publications on clinical trials with X‐ray contrast media: differences in quality between journals and decades
95. A quality assessment of randomized control trials of primary treatment of breast cancer
96. The use of baselines in clinical trials of bronchodilators
97. Manuscript review from a statistician's perspective
98. The task of a statistical referee
99. Indexes and boundaries for “quantitative significance” in statistical decisions
100. A note on the analysis of repeated measurements of the same subjects
101. Methods for assessing whether change depends upon initial value
102. On the spurious correlation between changes in blood pressure and initial values
103. Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis
104. Misleading statistics: predialysis norepinephrine and its change after hemodialysis
105. Reply
106. Relating change to initial value
107. Improving doctors' understanding of statistics (with discussion)
108. Inconsistencies in clinical decisions in obstetrics
109. Caesarean section for fetal distress
110. Principles of medical statistics. I‐The aim of the statistical method
111. Streptomycin treatment of pulmonary tuberculosis
112. Statisticians in medical schools
113. Preface
114. Misleading statistics: the quality of textbooks in medical statistics
115. Sulfinpyrazone in the prevention of sudden death after myocardial infarction
116. Possible prevention of neural‐tube defects by periconceptional vitamin supplementation
117. Survival of patients with breast cancer attending Bristol Cancer Help Centre